Literature DB >> 2415113

Drug-binding properties of human alpha-foetoprotein.

K Hirano, Y Watanabe, T Adachi, Y Ito, M Sugiura.   

Abstract

The drug-binding properties of human alpha-foetoprotein (alpha FP) were investigated by a fluorescence-spectral method. Human alpha FP was shown to bind to albumin's site I marker (warfarin, phenylbutazone), site II marker (L-tryptophan), but not site III marker (cholic acid, digoxin). The binding of human alpha FP towards lower alcohols was examined, and this binding seems to depend partly on the hydrophobicity of the ligands. The binding of human alpha FP is discussed in comparison with human serum albumin or rat alpha FP.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415113      PMCID: PMC1152721          DOI: 10.1042/bj2310189

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  20 in total

1.  SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.

Authors:  L K CHRISTENSEN; J M HANSEN; M KRISTENSEN
Journal:  Lancet       Date:  1963-12-21       Impact factor: 79.321

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  The study of lipid-protein interactions in membranes by fluorescent probes.

Authors:  D F Wallach; E Ferber; D Selin; E Weidekamm; H Fischer
Journal:  Biochim Biophys Acta       Date:  1970-03-17

4.  The immunological crossreaction between human alpha-fetoprotein and serum albumin and its relation with the binding ability.

Authors:  K Hirano; Y Watanabe; T Adachi; Y Ito; M Sugiura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-12       Impact factor: 1.645

5.  Carrier proteins in human fetal serum: bilirubin-binding abilities of albumin, alpha-fetoprotein and ligandin.

Authors:  K Hirano; Y Watanabe; T Adachi; M Sugiura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-02       Impact factor: 1.645

6.  Structural analysis of human and bovine alpha-fetoprotein by electron microscopy, image processing, and circular dichroism.

Authors:  A J Luft; F L Lorscheider
Journal:  Biochemistry       Date:  1983-12-06       Impact factor: 3.162

7.  alpha foetoprotein and serum albumin show sequence homology.

Authors:  E Ruoslahti; W D Terry
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

8.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

9.  Removal of fatty acids from serum albumin by charcoal treatment.

Authors:  R F Chen
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

10.  Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.

Authors:  F Hervé; K Rajkowski; M T Martin; P Dessen; N Cittanova
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

View more
  3 in total

Review 1.  Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding.

Authors:  F Hervé; S Urien; E Albengres; J C Duché; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

2.  Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Xiaomei I Liu; Jeremiah D Momper; Natella Y Rakhmanina; Dionna J Green; Gilbert J Burckart; Tim R Cressey; Mark Mirochnick; Brookie M Best; John N van den Anker; André Dallmann
Journal:  Clin Pharmacokinet       Date:  2020-11       Impact factor: 6.447

3.  Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.

Authors:  F Hervé; K M Rajkowski; M T Martin; P Dessen; N Cittanova
Journal:  Biochem J       Date:  1986-10-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.